Status:

COMPLETED

Ca-hydroxyapatite, Fluoroapatite, and Mg-Zn-hydroxyapatite for Dentin Hypersensitivity Management

Lead Sponsor:

I.M. Sechenov First Moscow State Medical University

Conditions:

Dentin Hypersensitivity

Eligibility:

All Genders

35-45 years

Phase:

PHASE4

Brief Summary

This will be a double-blind, randomized, three-arm parallel groups study of the effect of toothpastes containing Ca-hydroxyapatite (HAP), Mg-Zn-hydroxyapatite (Zn-Mg-HAP), or fluoroapatite (FAP). The...

Detailed Description

Background: Dentin hypersensitivity (DH) represents a sharp, short pain arising from exposed dentin in response to various stimuli which cannot be ascribed to any other form of dental defect or pathol...

Eligibility Criteria

Inclusion

  • aged between 35 and 45 years
  • signed an approved Informed Consent Form, authorizing the participation in the trial and the use of the results of the trial for educational purposes and for the publication
  • the diagnosis of dentin hypersensitivity stated clinically
  • a premolar or first molar with an abrasive cervical defect of at least 1 millimeter, and not deeper than 1.5 millimeter, as measured by placing a periodontal probe into the deepest part of the cervical lesion; no mesial, distal or buccal restorations (to avoid confounding hypersensitivity)
  • a hypersensitivity score of 2 or higher on the Shiff scale with standardized air-blast stimulation
  • no other tooth in the same quadrant exhibiting hypersensitivity

Exclusion

  • medical and pharmacotherapeutic histories that may compromise the protocol (pregnancy or breastfeeding, allergies to toothpastes ingredients, eating disorders)
  • systemic conditions that are etiologic to dentin hypersensitivity (e.g., chronic acid regurgitation)
  • excessive dietary or environmental exposure to acids
  • periodontal surgery in the preceding 3 months
  • orthodontic appliance treatment within previous 3 months
  • teeth or supporting structures with any other painful pathology or defects
  • teeth restored in the preceding 3 months
  • abutment teeth for fixed or removable prostheses
  • extensively restored teeth and those with restorations extending into the test area.

Key Trial Info

Start Date :

April 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 19 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04896294

Start Date

April 24 2021

End Date

July 19 2021

Last Update

October 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Dentistry of Sechenov University

Moscow, Russia, 121059